Nurturing a transnational system of innovation /Jerome H. Reichman Shaping a fair international IPR-regime in a globalized world. Some parameters for public policy /Thomas Dreier From huts to labs and back again. Stimulating the production of biodiversity-based drugs while ensuring an equitable sharing of the benefits flowing thereby /Gustavo Ghidini and Emanuela Arezzo Regulating protection, preservation and technology transfer of biodiversity-based drugs. Patents, contracts and local working requirements under the microscope /Geertrui Van Overwalle International price discrimination and market segmentation for patented pharmaceuticals in the EU : a social welfare analysis /Klaus Stegemann International price discrimination and market segmentation for patented pharmaceuticals in the EU. A social welfare analysis : a comment /Carsten Fink The Doha Waiver and its effects on the nature of the TRIPS system and on competition law. The impact of human rights /Thomas Cottier The so-called "waiver compromise" of Doha and Hong Kong. About contested concepts of the nature of the international intellectual property system : a comment /Christine Godt.
Bibliography, etc. Note
Includes bibliographical references.